Stockreport

Geron Announces Publication of Analyses Comparing Real World Data to IMbark Phase 2 in Annals of Hematology

Geron Corporation  (GERN) 
Last geron corporation earnings: 3/12 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: geron.com/investors
PDF Analyses Suggest Survival Benefit Associated with Imetelstat Treatment in Comparison to Best Available TherapyOverall Survival is Primary Endpoint for Ongoing Phase 3 Cl [Read more]